Combined androgen and antimetabolite therapy of advanced female breast cancer. A report of the cooperative breast cancer group
Autor: | I S, Goldenberg, N, Sedransk, H, Volk, A, Segaloff, R M, Kelley, C R, Haines |
---|---|
Rok vydání: | 1975 |
Předmět: | |
Zdroj: | Cancer. 36(2) |
ISSN: | 0008-543X |
Popis: | A clinical trial of androgen and antimetabolite therapy of advanced female breast cancer was conducted in 110 patients by the Cooperative Breast Cancer Group. An objective regression rate of 20% was achieved in women receiving oral testolactone, 6% in patients given intravenous fluorouracil alone, and 14% when the androgen and antimetabolite were administered together. This randomized trial according to the CBCG protocol did not produce the high regression rate noted previously in a nonrandomized, nonprotocol evaluation of these drugs. |
Databáze: | OpenAIRE |
Externí odkaz: |
Pro tento záznam nejsou dostupné žádné jednotky.